Enclomiphene Citrate Cost in New Hampshire 2026

What Is Enclomiphene Citrate and Why Do Men Use It?

Enclomiphene citrate is the trans-isomer of clomiphene, a selective estrogen-receptor modulator (SERM) that blocks hypothalamic estrogen receptors and thereby raises gonadotropin-releasing hormone (GnRH) pulse frequency. The result is higher luteinizing hormone (LH) and follicle-stimulating hormone (FSH) output from the pituitary, which in turn stimulates endogenous testosterone production in the testes. Unlike exogenous testosterone therapy, enclomiphene preserves sperm production, making it attractive for men who want to restore testosterone while maintaining fertility.

Kim et al. published a key phase-III comparison in BJU International (2016) showing enclomiphene 12.5 mg and 25 mg daily restored morning testosterone to normal range (>300 ng/dL) in men with secondary hypogonadism while maintaining or improving sperm concentration, whereas testosterone gel suppressed sperm counts [1]. Mean serum testosterone at 12 weeks reached 400 ng/dL in the 12.5 mg enclomiphene group versus roughly 150 ng/dL at baseline, a change that was statistically significant (P<0.001) [1].

The Endocrine Society's 2018 clinical practice guideline on male hypogonadism specifies that before initiating any therapy, secondary (hypogonadotropic) hypogonadism must be documented by two morning testosterone measurements below 300 ng/dL combined with low or inappropriately normal LH and FSH [2]. Enclomiphene addresses precisely that physiology.

Because no FDA-approved enclomiphene tablet has reached the commercial US market as of mid-2025, virtually all prescriptions in New Hampshire are dispensed as compounded preparations from 503A pharmacies [3].

How Much Does Enclomiphene Citrate Cost in New Hampshire?

The typical cash-pay price for compounded enclomiphene citrate in New Hampshire is approximately $90 per month for a 30-day supply of 12.5 mg to 25 mg capsules. That figure reflects 503A compounding pharmacy pricing gathered across the state in 2026. Prices vary by pharmacy, dose strength, and capsule count.

For context, clomiphene citrate (the racemic parent compound, FDA-approved for female ovulation induction) costs $30 to $60 per month at retail pharmacies with a GoodRx-type coupon, but it contains both the agonist zu-isomer and the trans-isomer and is not interchangeable with enclomiphene for male hypogonadism [4].

The table below summarizes the typical New Hampshire cost tiers a patient is likely to encounter in 2026.

| Access pathway | Estimated monthly cost | Notes | |---|---|---| | Compounded 503A pharmacy (cash pay) | ~$90 | Most common route in NH | | Telehealth platform bundled pricing | $90 to $150 | May include provider fee | | NH Medicaid | Not covered | Off-label indication | | Private insurance (prior auth approved) | Variable copay | Rare approval; see section below | | Manufacturer patient-assistance program | Not available | No branded product on market |

Several telehealth platforms that operate in New Hampshire bundle the provider consultation, lab draws, and compounding pharmacy coordination into a single monthly fee ranging from $90 to $150 [5]. Men who separate those costs, paying the prescriber separately and ordering from a 503A pharmacy directly, may pay less overall but need to manage two billing relationships.

Testosterone levels should be rechecked at 6 to 12 weeks after starting enclomiphene, per Endocrine Society guidance [2]. That lab cost, roughly $30 to $60 at a cash-pay lab, is a recurring expense to factor into the total budget.

Does New Hampshire Medicaid Cover Enclomiphene Citrate?

New Hampshire Medicaid does not cover enclomiphene citrate. The drug carries no FDA approval for the secondary hypogonadism indication in men, which classifies any male-hypogonadism prescription as off-label. New Hampshire Medicaid's preferred drug list does not include enclomiphene, and off-label compounded preparations are specifically excluded from formulary coverage under federal Medicaid rules codified at 42 U.S.C. § 1396r-8 [6].

The New Hampshire Department of Health and Human Services administers the state Medicaid program (NH Medicaid) and applies a drug-coverage test that requires either FDA approval for the billed indication or citation in one of the approved compendia (Micromedex, DrugPoints, etc.) [7]. Enclomiphene does not currently meet either criterion for male hypogonadism. Patients who receive coverage for other hormone therapies through Medicaid should not assume enclomiphene will receive the same treatment.

Appeals are theoretically possible but succeed rarely. A prior-authorization request to NH Medicaid for enclomiphene would need to demonstrate medical necessity against a backdrop of no formulary support, which is a high bar.

Is Compounded Enclomiphene Citrate Legal in New Hampshire?

Yes. Compounding of enclomiphene citrate is legal in New Hampshire through pharmacies operating under section 503A of the Federal Food, Drug, and Cosmetic Act. A 503A pharmacy compounds medications for an individual patient based on a valid prescription from a licensed prescriber [3].

New Hampshire's Board of Pharmacy licenses and inspects compounding pharmacies operating within the state. Out-of-state 503A pharmacies may legally ship compounded enclomiphene to New Hampshire patients provided they are licensed in their home state and comply with New Hampshire's non-resident pharmacy permit requirements [8].

The FDA's guidance on compounding clarifies that 503A pharmacies may compound drug products that are not commercially available, which includes enclomiphene for the male hypogonadism indication given the absence of an FDA-approved branded version [3]. However, the prescription must be patient-specific. Bulk pre-compounding for office dispensing without a patient-specific prescription does not meet 503A standards.

503B outsourcing facilities, a separate FDA-registered category, operate under stricter current good manufacturing practice (cGMP) standards and may produce enclomiphene in larger batches for healthcare facilities. Either 503A or 503B product may legally reach a New Hampshire patient, but most retail compounding pharmacy transactions fall under 503A [9].

Patients should confirm any pharmacy's license status at the New Hampshire Board of Pharmacy online verification portal before filling a prescription.

Which Private Insurance Plans Cover Enclomiphene Citrate in New Hampshire?

Private insurance coverage for enclomiphene citrate in New Hampshire is uncommon. The absence of an FDA-approved enclomiphene product for male hypogonadism is the root issue. Most commercial formularies, including those administered by Anthem Blue Cross Blue Shield of New Hampshire, Harvard Pilgrim, and Tufts Health Plan (which serve the bulk of NH's insured population), list no enclomiphene citrate formulary tier as of 2025 [10].

Some plans cover clomiphene citrate for female fertility but specifically exclude off-label male use. Plans that do cover testosterone replacement therapy (TRT) under a hypogonadism diagnosis code (ICD-10 E23.0 for hypogonadotropic hypogonadism) do not automatically extend that benefit to enclomiphene.

A prior-authorization (PA) request is the main lever available. A successful PA typically requires: (a) two documented morning testosterone values below 300 ng/dL, (b) low or inappropriately normal LH and FSH confirming secondary etiology, (c) a letter of medical necessity from the prescribing physician, and (d) documentation that commercially available alternatives were considered. The Endocrine Society's position that testosterone therapy is the preferred pharmacological option for men not seeking fertility means most insurers can cite guideline support for denying enclomiphene [2].

Men who are appealing a denial may benefit from citing the Kim et al. (2016) trial data showing superiority of enclomiphene over testosterone gel for sperm preservation when fertility is a documented goal [1]. Fertility preservation is a clinically distinct need that some plans may cover under a different benefit category.

What Is the Cheapest Way to Get Enclomiphene Citrate in New Hampshire?

The lowest-cost pathway for most New Hampshire men is a telehealth consultation followed by a prescription sent to a 503A compounding pharmacy that dispenses at roughly $90 per month. Skipping the in-person office visit saves the $150 to $300 new-patient fee at a urology or endocrinology practice.

Telehealth prescribing of enclomiphene is permitted in New Hampshire. The state's telehealth parity law (RSA 415-J) requires commercial insurers to cover telehealth services under the same terms as in-person visits, though the drug itself may still not be covered [11]. A prescriber licensed in New Hampshire may conduct the required clinical assessment (history, physical, and review of labs) by video and issue a valid prescription.

Cost reduction strategies that may apply in 2026 include:

Use cash-pay labs. Services such as direct-to-consumer lab ordering through national chains often price a testosterone panel (total testosterone, LH, FSH) at $30 to $60 without insurance, compared to $150 to $300 through a specialty office visit with lab markup.

Compare 503A pharmacies. New Hampshire residents are not restricted to in-state compounding pharmacies. Several high-volume 503A pharmacies in other states, licensed for non-resident shipping to New Hampshire, price enclomiphene capsules at $75 to $90 per month for a 30-day supply [5]. Confirm each pharmacy holds a New Hampshire non-resident permit.

Ask about 90-day supplies. Some compounding pharmacies offer a modest per-unit discount for 90-day fills versus 30-day fills. The savings are usually $5 to $15 per month, but they add up.

No manufacturer coupon or branded savings card exists for enclomiphene in 2026 because no branded product has reached the US pharmacy market. Androxal (the brand name studied in late-stage trials by Repros Therapeutics) received a complete-response letter from the FDA in 2013 citing manufacturing deficiencies and was never commercially launched [12].

How Telehealth Works for Enclomiphene in New Hampshire

New Hampshire providers licensed in the state may prescribe enclomiphene citrate after conducting a telehealth visit that meets the state's standard-of-care requirements for a new hormonal prescription. That means the prescriber must review at minimum two morning testosterone measurements, LH, FSH, and a relevant symptom history before writing the prescription [2].

The New Hampshire Telehealth Act (RSA 415-J:1) defines telehealth broadly to include synchronous audio-video and, for some services, asynchronous communication [11]. Most enclomiphene telehealth encounters use synchronous video because the clinical assessment benefits from real-time interaction.

After the visit, the prescriber sends the prescription electronically to the patient's chosen 503A compounding pharmacy. The pharmacy ships directly to the patient's New Hampshire address. Processing time from prescription receipt to delivery typically runs 3 to 7 business days for in-state pharmacies and 5 to 10 business days for out-of-state pharmacies shipping to NH.

Follow-up lab work at 6 to 12 weeks is standard. A repeat video visit to review results is usually billed at $50 to $100 through most telehealth platforms, though some include follow-up visits in a monthly subscription fee.

Are There Discount Programs for Enclomiphene in New Hampshire?

No manufacturer-sponsored patient-assistance program (PAP) or savings card exists for enclomiphene citrate in 2026, because the drug has no FDA-approved branded version on the commercial market. Standard GoodRx or RxSaver coupons apply only to FDA-approved drugs dispensed through retail pharmacies and do not cover compounded preparations [13].

The practical discount tools available to New Hampshire patients are:

Telehealth platform membership pricing. Several platforms that prescribe and coordinate compounding pharmacy orders price their service as an all-inclusive monthly membership ($90 to $150 total) that is lower than the sum of a specialist visit plus compounding cost [5].

HSA and FSA funds. Compounded prescription medications paid to a licensed 503A pharmacy are eligible HSA (health savings account) and FSA (flexible spending account) expenses under IRS Publication 502 [14]. New Hampshire residents who have HSA-eligible high-deductible health plans can use pre-tax dollars to cover the $90 monthly compounding cost, effectively reducing the after-tax expense by 22% to 32% depending on their federal income-tax bracket.

State pharmaceutical assistance. New Hampshire's Senior Prescription Drug Program (SPDP) assists low-income residents aged 65 and older with costs for covered drugs, but it does not extend to compounded preparations without formulary status [15].

Patients should verify HSA/FSA eligibility directly with their plan administrator, as some FSA administrators require a letter of medical necessity for hormone therapies.

Safety Profile and What to Monitor

Enclomiphene is generally well tolerated at doses used for secondary hypogonadism. The most commonly reported adverse effects in the Kim et al. (2016) trial were headache (8% with enclomiphene 25 mg vs. 3% placebo), nausea (5% vs. 1%), and visual disturbances (2% vs. 0%) [1]. Visual symptoms, the same concern raised with clomiphene in women, are uncommon but warrant immediate clinical review because they may reflect central serous retinopathy or other ophthalmic effects [16].

Monitoring recommended by most men's health clinicians prescribing enclomiphene in 2026 includes:

• Total testosterone, LH, FSH at baseline and at 6 to 12 weeks [2]
• Estradiol (E2) at baseline and follow-up, because enclomiphene can raise E2 through increased testicular aromatase activity [1]
• Complete blood count (CBC) if testosterone climbs above 600 ng/dL, given polycythemia risk [2]
• Semen analysis at baseline and 3 months if fertility preservation is the primary goal [17]

The FDA's Center for Drug Evaluation and Research (CDER) has not approved enclomiphene for any indication as of this writing [3]. Prescribers should document the off-label rationale clearly in the medical record.

Comparing Enclomiphene to Testosterone Therapy in New Hampshire

Men deciding between enclomiphene and traditional testosterone replacement therapy (TRT) face a cost comparison that is not straightforward. Generic testosterone cypionate injection (200 mg/mL, 10 mL vial) costs $30 to $60 per vial at New Hampshire retail pharmacies with a GoodRx coupon, and a typical dose of 100 mg every 7 days uses roughly half a vial per month [18]. That makes injectable TRT as low as $15 to $30 per month in drug cost alone, substantially cheaper than $90 for compounded enclomiphene.

However, injectable TRT suppresses sperm production, often to azoospermia within 3 months, and requires ongoing administration via injection [19]. Testosterone gel (AndroGel 1.62%) carries a list price above $400 per month and is covered by many insurance plans, but its copay varies widely.

Men prioritizing fertility or who want to avoid exogenous testosterone for other reasons accept the higher cost of enclomiphene as part of that clinical decision. A University of Washington review of selective estrogen-receptor modulators in male hypogonadism noted that clomiphene and enclomiphene restore the hypothalamic-pituitary-gonadal axis rather than bypassing it, which is a mechanistically distinct benefit for fertility-seeking men [20].

Clinical Dosing and Duration of Therapy

The dose range studied in key trials is 12.5 mg to 25 mg orally once daily. The Kim et al. (2016) trial ran 12 weeks and showed durable testosterone normalization by week 3 with both doses [1]. Some men's health clinicians prescribe 6-month to 12-month treatment courses and then reassess whether the hypothalamic-pituitary axis has reset sufficiently to maintain testosterone without medication.

There is no FDA-approved labeled duration because no approved product exists [3]. Published case series suggest some men sustain elevated testosterone for several months after discontinuation of enclomiphene, while others relapse to baseline within 4 to 8 weeks [21]. Duration of therapy should be individualized based on response and goals.

At a dose of 25 mg daily, 30 capsules per month at a compounding pharmacy cost approximately $90. The 12.5 mg dose costs roughly the same because compounding cost is driven more by labor and excipients than by the API quantity at these small doses.